Recorded Chinese product: 氢氧化铝凝胶氢氧化铝凝胶
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 福建省永安药业有限责任公司Chinese legal name: 福建省永安药业有限责任公司
主要成分Active Ingredients
- 氢氧化铝Qingyang Hualv
药物知识说明
氢氧化铝是一种在国家药监局注册认定的药品。该药品含有氢氧化铝-ef7f4934等成分。
该药品关联的活性成分包括：氢氧化铝Qingyang Hualv。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：福建省永安药业有限责任公司Chinese legal name: 福建省永安药业有限责任公司。
您可以探索含有相同成分的其他药品：氢氧化铝-ef7f4934成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氢氧化铝凝胶) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氢氧化铝Qingyang Hualv.
Manufacturers recorded for this product: 福建省永安药业有限责任公司Chinese legal name: 福建省永安药业有限责任公司.
Explore other medicines containing the same ingredient: 氢氧化铝 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氢氧化铝凝胶Recorded Chinese product: 氢氧化铝凝胶
- 规格Specification: 4%(g/ml)4 %(g/ml)
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 福建省永安药业有限责任公司Chinese legal name: 福建省永安药业有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H35021085
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H35021085
Manufacturer
Chinese legal name: 福建省永安药业有限责任公司
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H35021085
生产企业
福建省永安药业有限责任公司
适应症
用于缓解胃酸过多引起的胃痛、胃灼热感（烧心）、反酸。
用法用量
口服。成人一次5-8毫升，一日3次，餐前1小时服用。
不良反应
1.老年人长期服用，可致骨质疏松。|2.肾功能不全患者长期应用可能会有铝蓄积中毒，出现精神症状。
禁忌
阑尾炎或急腹症时，服用本品可使病情加重，可增加阑尾穿孔的危险，应禁用。
注意事项
1.本品连续使用不得超过7天，症状未缓解，请咨询医师或药师。|2.儿童用量请咨询医师或药师。|3.骨折患者不宜服用，这是由于不溶性磷酸铝复合物的形成，导致血清磷酸盐浓度降低及磷自骨内移出。|4.本品能妨碍磷的吸收，长期服用能引起低磷血症；低磷血症（如吸收不良综合征）患者慎用。|5.本品有便秘作用，故长期便秘者应慎用。|6.如服用过量或出现严重不良反应，应立即就医。|7.对本品过敏者禁用，过敏体质者慎用。|8.本品性状发生改变时禁止使用。|9.请将本品放在儿童不能接触的地方。|10.儿童必须在成人监护下使用。|11.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密封，置阴凉处。
规格
4%(g/ml)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.